TIS 0.00% 0.0¢ tissue therapies limited

well, page-16

  1. 430 Posts.
    lightbulb Created with Sketch. 7
    Price Reaction.
    A comforting price reaction to some information, at time of writing.
    The information is of course targeted at new money, which is good of course.
    I wish and hope the company can keep a regular information flow, for the old money, already converted, current shareholders.
    I suggest this is as important to the company to keep the s/price as possitive as possible so that any further capital raising will be at as high as possible.
    Had a better information flow been made then I suspect the price would not have been as low as it has been, and therefor our mystery new shareholder may have had to increase the coffers more to get his lot, or for the same amount of capital there would have been less dilution.
    I think there will have to be a capital raising as in making application for the US trials I am sure the company will have to show it has the funds to complete it. The current balance does not suggest that, and projections of forward sales are mot material.
    So expect the raising after the CE announcement when the price will get a substantial kick, whenever that may be.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.